Molecular & Precision Med TRI-CON is a conference dedicated to the emerging developments and advancements of therapeutic, diagnostic, and technology approaches.
Molecular & Precision Med TRI-CON covers topics such as:
- Genomics
- PCR & NGS-Based Molecular Diagnostics
- Precision Medicine
- Genomic Sample Prep, Assay Development and Validation
- Clinical NGS Diagnostics
- Diagnostics
- Personalized Diagnostics
- Molecular Diagnostics
- Circulating Tumor Cells and Liquid Biopsy
- Cancer Molecular Markers
- Precision Medicine
- Digital Pathology
- Clinical NGS Diagnostics
- PCR & NGS-Based Molecular Diagnostics
- Molecular Diagnostics for Infectious Disease
- Genomic Sample Prep, Assay Development and Validation
- Informatics
- Integrated Pharma Informatics
- Bioinformatics for Big Data
- Cancer
- Circulating Tumor Cells and Liquid Biopsy
- Cancer Molecular Markers
- Translational Models in Oncology and Immuno-Oncology
- Cancer Immunotherapy
- Other
- Circulating Cell-Free DNA
- New Frontiers in CRISPR-Based Gene Editing
- Biomarkers for Cancer Immunotherapy
- Point-of-Care Diagnostics
- Microbiome-Based Precision Medicine - NEW
- Genomic Knowledge Bases, Annotation and Interpretation, Analysis and Visualization
- Commercialization of Molecular Diagnostics
Molecular & Precision Med TRI-CON brings together senior attendees from pharmaceutical and biotech companies with responsibilities in:
- Clinical research and Development
- Clinical trials
- Clinical operations
- Medical affairs
- Drug development and research
- Biomarkers
- Oncology
- Imaging
